Skip to main content
. Author manuscript; available in PMC: 2014 Jan 15.
Published in final edited form as: Clin Cancer Res. 2012 Dec 4;19(2):500–507. doi: 10.1158/1078-0432.CCR-12-2153

Table 5.

Association between CYP2D6 phenotype and disease event during the 5 years of drug therapy in arms A and B

Tamoxifen only (Arm A) Tamoxifen followed by anastrozole (Arm B)
Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value
PM/PM relative to EM/EM 2.45 (1.05, 5.73) 0.04 0.60 (0.15, 2.37) 0.47
EM/PM and PM/IM relative to EM/EM 1.67 (0.95, 2.93) 0.07 0.76 (0.43, 1.31) 0.32
EM/IM and IM/IM relative to EM/EM 1.23 (0.58, 2.61) 0.60 1.02 (0.52, 2.01) 0.96